Effects of OspA vaccination on Lyme disease serologic testing

Journal of Clinical Microbiology

Volumn 37, Issue 11, 1999, Pages 3718-3721

  Aguero Rosenfeld, Maria E ^a   Roberge, Janet ^a   Carbonaro, Carol A ^a   Nowakowski, John ^a   Nadelman, Robert B ^a   Wormser, Gary P ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; MEMBRANE PROTEIN;

ANTIBODY DETECTION; ARTICLE; BORRELIA BURGDORFERI; CLINICAL TRIAL; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; INTRAMUSCULAR DRUG ADMINISTRATION; LYME DISEASE; NORMAL HUMAN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEROLOGY; VACCINATION;

EID: 0032882610     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.11.3718-3721.1999     Document Type: Article

References (13)

1. American College of Physicians. 1997. Guidelines for the laboratory evaluation in the diagnosis of Lyme disease. Ann. Intern. Med. 127:1106-1108.
2. Anonymous. 1999. Lyme disease vaccine approved. JAMA 281:405.
3. Centers for Disease Control and Prevention. 1995. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morbid. Mortal. Weekly Rep. 44:590-591.
4. Engstrom, S. M., E. Shoop, and R. C. Johnson. 1995. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 33:419-427.
5. Johnson, B. J. B., K. E. Robbins, R. E. Bailey, B.-L. Cao, S. L. Sviat, R. B. Craven, L. W. Mayer, and D. T. Dennis. 1996. Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J. Infect. Dis. 174:346-353.
6. Sivak, S., M. E. Aguero-Rosenfeld, J. Nowakowski, R. B. Nadelman, and G. P. Wormser. 1996. Accuracy of IgM immunoblotting to confirm the clinical diagnosis of early Lyme disease. Arch. Intern. Med. 156:2105-2109.
7. Steere, A. C., V. K. Sikand, F. Meurice, D. L. Parenti, E. Fikrig, R. T. Schoen, J. Nowakowski, C. H. Schmid, S. Laukemp, C. Busarino, D. S. Krause, and the Lyme Disease Vaccine Study Group. 1998. N. Engl. J. Med. 339:209-215.
8. Strickland, G. T., A. C. Karp, and A. Mathews. 1997. Utilization and cost of serologic tests for Lyme disease in Maryland. J. Infect. Dis. 176:819-821.
9. Trevejo, R. T., P. J. Krause, V. K. Sikand, M. E. Schriefer, R. Ryan, T. Lapore, W. Porter, and D. T. Dennis. 1999. Evaluation of two-test serodiagnostic method for early Lyme disease in clinical practice. J. Infect. Dis. 179:931-938.
10. Tugwell, P., D. T. Dennis, A. Weinstein, G. Wells, B. Shea, G. Nichol, R. Hayward, R. Lightfoot, P. Baker, and A. C. Steere. 1997. Laboratory evaluation in the diagnosis of Lyme disease. Ann. Intern. Med. 127:1109-1123.
11. Wormser, G. P. 1995. Prospects for a vaccine to prevent Lyme disease in humans. Clin. Infect. Dis. 21:1267-1274.
12. Wormser, G. P., J. Nowakowski, R. B. Nadelman, I. Schwartz, D. McKenna, D. Holmgren, and M. Aguero-Rosenfeld. 1998. Efficacy of an OspA vaccine preparation for prevention of Lyme disease in New York State. Infection 26:208-212.
13. Zhang, Y.-Q., D. Mathiesen, C. P. Kolbert, J. Anderson, R. T. Schoen, E. Fikrig, and D. H. Persing. 1997. Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection. J. Clin. Microbiol. 35:233-238.